Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Product containing amiloride and atenolol and hydrochlorothiazide (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Atenolol (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has manufactured dose form |
A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrochlorothiazide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amiloride hydrochloride (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has manufactured dose form |
Oral capsule |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Atenolol-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Product containing amiloride hydrochloride and hydrochlorothiazide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Amiloride-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Hydrochlorothiazide-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Atenolol (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
Atenolol (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator value |
50 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength denominator unit (attribute) |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Hydrochlorothiazide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
Hydrochlorothiazide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator value |
25 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength denominator unit (attribute) |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amiloride hydrochloride (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
Amiloride hydrochloride (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator value |
2.5 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength denominator unit (attribute) |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
Hydrochlorothiazide (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator value |
25 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
Amiloride hydrochloride (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has presentation strength numerator value |
2.5 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has unit of presentation |
Capsule (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has precise active ingredient |
Amiloride hydrochloride (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has precise active ingredient |
Hydrochlorothiazide (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has precise active ingredient |
Atenolol (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Count of base of active ingredient |
trois |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Is a |
Product containing only amiloride and atenolol and hydrochlorothiazide in oral dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Plays role |
Potassium-sparing diuretic therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|